ATE262337T1 - Azasteroidverbindung zur behandlung von alopezie, hirsutismus und seborrhoe - Google Patents

Azasteroidverbindung zur behandlung von alopezie, hirsutismus und seborrhoe

Info

Publication number
ATE262337T1
ATE262337T1 AT98933945T AT98933945T ATE262337T1 AT E262337 T1 ATE262337 T1 AT E262337T1 AT 98933945 T AT98933945 T AT 98933945T AT 98933945 T AT98933945 T AT 98933945T AT E262337 T1 ATE262337 T1 AT E262337T1
Authority
AT
Austria
Prior art keywords
hirsutism
aopezia
seborrhoe
treatment
azasteroid compound
Prior art date
Application number
AT98933945T
Other languages
English (en)
Inventor
Koichi Kojima
Takakazu Hamada
Shiroh Yosioka
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE262337T1 publication Critical patent/ATE262337T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
AT98933945T 1997-07-29 1998-07-27 Azasteroidverbindung zur behandlung von alopezie, hirsutismus und seborrhoe ATE262337T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20313697 1997-07-29
PCT/JP1998/003337 WO1999006050A1 (en) 1997-07-29 1998-07-27 Remedial agent for baldness and other diseases

Publications (1)

Publication Number Publication Date
ATE262337T1 true ATE262337T1 (de) 2004-04-15

Family

ID=16469018

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98933945T ATE262337T1 (de) 1997-07-29 1998-07-27 Azasteroidverbindung zur behandlung von alopezie, hirsutismus und seborrhoe

Country Status (21)

Country Link
US (1) US6380179B1 (de)
EP (1) EP0998930B1 (de)
KR (1) KR20010022066A (de)
CN (1) CN1129433C (de)
AT (1) ATE262337T1 (de)
AU (1) AU733830B2 (de)
BR (1) BR9811293A (de)
CA (1) CA2298851A1 (de)
DE (1) DE69822636T2 (de)
DK (1) DK0998930T3 (de)
ES (1) ES2218840T3 (de)
HU (1) HUP0003159A3 (de)
ID (1) ID24566A (de)
IL (1) IL134199A0 (de)
NO (1) NO20000469L (de)
NZ (1) NZ502537A (de)
PL (1) PL338414A1 (de)
PT (1) PT998930E (de)
RU (1) RU2193887C2 (de)
TR (1) TR200000263T2 (de)
WO (1) WO1999006050A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE265854T1 (de) * 1997-02-26 2004-05-15 Sankyo Co Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
WO2005074985A2 (en) * 2004-02-02 2005-08-18 Schering Corporation Methods of modulating cd200 and cd200r
PL1898867T3 (pl) * 2005-06-24 2018-02-28 Arizona Board Of Regents, Acting On Behalf Of The University Of Arizona Sposób leczenia zaburzeń wzrostu włosów, takich jak łysienie androgenowe typu kobiecego, i użyteczne kompozycje
US20080108681A1 (en) * 2006-10-27 2008-05-08 Access Business Group International Llc Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions
US20120245205A1 (en) 2009-07-29 2012-09-27 Delong Mitchell A Compositions and methods for inhibiting hair growth
MX2010012945A (es) * 2010-11-24 2012-05-24 Fidel Ojeda Gomez Una formula para el control y eliminacion de seborrea y alopecia en el cuero cabelludo.
RU2477155C2 (ru) * 2011-04-27 2013-03-10 Закрытое акционерное общество "Патент-Фарм" Способ лечения андрогенетической алопеции

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
US5516768A (en) 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
IE76452B1 (en) 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
JP3030152B2 (ja) * 1992-02-03 2000-04-10 三共株式会社 ４−アザステロイド化合物
US5278159A (en) * 1992-10-06 1994-01-11 Merck & Co., Inc. Aryl ester derivatives of 3-oxo-4-aza-androstane 17-β-carboxylates as 5-α-reductase inhibitors
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
TW382595B (en) 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
JPH0873492A (ja) * 1994-06-28 1996-03-19 Sankyo Co Ltd アザステロイド類
US5629007A (en) 1995-03-21 1997-05-13 Eli Lilly And Company Method of preventing prostatic cancer development
US5635197A (en) 1995-03-21 1997-06-03 Eli Lilly And Company Treatment and prevention of prostatic cancer metastasis
JPH11513380A (ja) 1995-09-27 1999-11-16 メルク エンド カンパニー インコーポレーテッド ５−αレダクターゼ阻害剤によるアンドロゲン性脱毛症の予防方法
HUP9901870A3 (en) * 1996-02-05 1999-11-29 Sankyo Company Ltd Chuo Ku 5alfa-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof
ATE265854T1 (de) * 1997-02-26 2004-05-15 Sankyo Co Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
US6093722A (en) 1997-02-26 2000-07-25 Sankyo Company, Limited Method for treating prostate cancer

Also Published As

Publication number Publication date
BR9811293A (pt) 2000-08-29
EP0998930B1 (de) 2004-03-24
NZ502537A (en) 2002-11-26
PL338414A1 (en) 2000-11-06
CN1129433C (zh) 2003-12-03
WO1999006050A1 (en) 1999-02-11
DK0998930T3 (da) 2004-04-26
NO20000469D0 (no) 2000-01-28
PT998930E (pt) 2004-05-31
TR200000263T2 (tr) 2000-09-21
AU733830B2 (en) 2001-05-24
EP0998930A1 (de) 2000-05-10
HUP0003159A3 (en) 2001-07-30
CA2298851A1 (en) 1999-02-11
HUP0003159A2 (hu) 2001-04-28
KR20010022066A (ko) 2001-03-15
EP0998930A4 (de) 2002-06-12
IL134199A0 (en) 2001-04-30
US6380179B1 (en) 2002-04-30
CN1271285A (zh) 2000-10-25
HK1027290A1 (en) 2001-01-12
DE69822636D1 (de) 2004-04-29
NO20000469L (no) 2000-03-28
ES2218840T3 (es) 2004-11-16
AU8358598A (en) 1999-02-22
RU2193887C2 (ru) 2002-12-10
DE69822636T2 (de) 2005-01-05
ID24566A (id) 2000-07-27

Similar Documents

Publication Publication Date Title
DE60037892D1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
BR9709427A (pt) Oxa ácidos e compostos relacionados para tratamento de condições da pele
DE69738740D1 (de) Verwendung von Oestrogen Antagonisten und Oestrogen Agonisten zur Behandlung von pathologischen Zuständen
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
GR3033786T3 (en) Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof
BG104569A (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
ATE262337T1 (de) Azasteroidverbindung zur behandlung von alopezie, hirsutismus und seborrhoe
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
AU681021B2 (en) Indole derivative and medicine containing the same
HUT71512A (en) N-(3-chlorophenyl)-piperazine derivatives for producing alkyl-trazodon derivatives and process for producing them
DE69823650D1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
EP0711164A4 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
ATE220665T1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0998930

Country of ref document: EP

REN Ceased due to non-payment of the annual fee